Brand Name : EUDRAGIT® L 100

Germany

Compamed

Exhibiting

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Dosage Form : Capsule, Tablet

Grade : Oral

Evonik

Application : Controlled & Modified Release, Solubilizers

Excipient Details : EUDRAGIT® L 100, a functional delayed release polymer is used to increase solubility of poorly soluble products such as tablets, capsules, ODTs, etc.

Pharmacopoeia Ref : NA

Technical Specs : Available as powder; Other grades- EUDRAGIT® L 12,5

Ingredient(s) : METHACRYLIC ACID COPOLYMER TYPE A

Dosage Form : Capsule, Tablet

Grade : Oral

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Ingredient(s) : METHACRYLIC ACID COPOLYMER TYPE A

Dosage Form : Capsule, Tablet

Category : Controlled & Modified Release, Solubilizers

Brand : EUDRAGIT® L 100

Applications : EUDRAGIT® L 100, a functional delayed release polymer is used to increase solubility of poorly soluble products such as tablets, capsules, ODTs, etc.

Pharmacopoeia Ref : NA

Technical Specs : Available as powder; Other grades- EUDRAGIT® L 12,5

Grade : Oral

Excipients Web Link

Market Place

Looking for Pharmaceutical Excipients offered by Evonik? Find to address your drug delivery challenges on PharmaCompass.

Evonik

VISIT THE VIRTUAL BOOTH

Review portfolio & marketing content

CONTACT DETAILS

Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

PRESENTATION(s)

VIDEO(s)

DIGITAL CONTENT

43 CORPORATE CONTENT #SupplierSpotlight

3 DATA COMPILATION #PharmaFlow

243 NEWS #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

DEVELOPMENTS

7 Drugs in Development

SERVICES

API Manufacturing

Drug Product Manufacturing

API & Drug Product Development

KEY SERVICES

EXCIPIENTS

EXCIPIENTS BY INGREDIENTS

EXCIPIENTS BY APPLICATIONS

INSPECTIONS & REGISTRATIONS

Filters

01